SSM Health joins generic-drug partnership

in the news
ST. LOUIS, Mo. — In an effort to help patients avoid shortages and high costs associated with some generic drugs, St. Louis-based SSM Health is among several organizations partnering with Intermountain Healthcare to form a new not-for-profit generic pharmaceuticals company.
SSM Health is the non-profit corporate parent of St. Francis Hospital in Maryville. Intermountain Healthcare is a not-for-profit health system based in Salt Lake City that owns or administers 22 hospitals, 180 clinics and a health insurance plan.
Other corporate entities involved in the partnership include:
- Ascension, a Catholic health care organization based in St. Louis with the stated mission of delivering health care to all with a special emphasis on patients living in poverty.
- Trinity Health, a Michigan-based Catholic health care delivery system serving more than 30 million people across 22 states at 93 hospitals and 109 continuing-care locations that include Medicare/Medicaid-administered Programs of All-Inclusive Care for the Elderly (PACE), senior living facilities and home care and hospice services.
- The U.S. Department of Veterans Affairs, whose role is limited to support services and does not include financial support.
The new company intends to function as an FDA-approved manufacturer that will itself produce generic drugs or sub-contract production to qualified facilities.
According to a joint press release, the new company’s goal is to provide patients with “an affordable alternative to products from generic drug companies whose capricious and unfair pricing practices are damaging the generic drug market and hurting consumers.”
The organization also claims it will “seek to stabilize the supply of essential generic medications administered in hospitals, many of which have fallen into chronic shortage.”
The initiative “will result in lower costs and more predictable supplies of essential generic medicines, helping ensure that patients and their needs come first in the generic drug marketplace,” the release stated.
“The move by SSM Health and three other health systems and in partnership with the VA is a bold move to lower the cost of generic drugs and to provide a stable supply of generic drugs,” said St. Francis President and CEO Mike Baumgartner said this week.
As has been widely reported by the national news media, some generic drug manufacturers have been the object of criticism for allegedly unwarranted price increases and shortages.
“These activities have resulted in some generic drugs increasing in cost by more than 1,000 percent in just a few months for seemingly no reason,” the partnership release stated.
“Research into the actual costs of manufacturing and distributing generic drugs suggests that, in many instances, generic drug prices can be reduced to a fraction of their current costs, saving patients, and the healthcare systems that care for them, hundreds of millions of dollars each year.”
Another problem, according to Intermountain, is the existence of fewer suppliers, consolidation of production volumes and a concentration of market pricing power have affected the availability and cost of older generic medications that hospitals rely on every day to take care of critically ill patients.
The new company, the partnership claims, will bring together healthcare systems from around the country to help address “generic drug market failures.”
Dr. Marc Harrison, Intermountain president and CEO, said he believes the collaboration will be a game-changer for the generic drug market.
“It’s an ambitious plan,” Harrison said, “but health care systems are in the best position to fix the problems in the generic drug market. We witness, on a daily basis, how shortages of essential generic medications, or egregious cost increases for those same drugs, affect our patients.
“We are confident we can improve the situation for our patients by bringing much needed competition to the generic drug market.”
SSM Health president and CEO Laura Kaiser said that “all Americans deserve access” to quality, affordable care.
“The best way to control the rising cost of health care in the U.S. is for payers, providers and pharmaceutical companies to work together and share responsibility in making care affordable,” Kaiser said. “Until that time, initiatives such as this will foster our ability to protect patients from drug shortages and price increases that limit their ability to access the care they need.”
